Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis
Public ClinicalTrials.gov record NCT03587831. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03587831
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 48 participants
Conditions and interventions
Conditions
Interventions
- Lifestyle Modification Counseling Behavioral
- Vertical Sleeve Gastrectomy Procedure
Behavioral · Procedure
Eligibility (public fields only)
- Age range
- 30 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2021
- Primary completion
- Sep 14, 2026
- Completion
- Sep 14, 2026
- Last update posted
- May 7, 2026
2021 – 2026
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of San Fransisco | San Francisco | California | 94143 | Recruiting |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | Not yet recruiting |
| Minneapolis VA Medical Center | Minneapolis | Minnesota | 55417 | Not yet recruiting |
| University of Minnesota | Minneapolis | Minnesota | 55455 | Completed |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated NASH - Nonalcoholic Steatohepatitis trials
Other public records listing NASH - Nonalcoholic Steatohepatitis. Sorted by last update posted; newest first. Not a recommendation.
- NCT04505436: Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects Active, not recruiting
- NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) Active, not recruiting
- NCT04054310: Non-Invasive Quantification of Liver Health in NASH (N-QUAN) Recruiting
- NCT03900429: A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis Active, not recruiting
- NCT05165446: Novel MRE Technique to Assess a Risk Factor for Liver Cancer Active, not recruiting
- NCT04383951: Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03587831, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03587831 live on ClinicalTrials.gov.